ArticleCancer medicine2020

High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.

Jouni Kujala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.